Plasma Calcitonin Gene-Related Peptide: A Potential Biomarker for Diagnosis and Therapeutic Responses in Pediatric Migraine
Background: Plasma calcitonin gene-related peptide (CGRP) plays a key role in the migraine pathophysiology. This study aimed to investigate its role in predicting diagnosis and outcome of pharmacotherapy in pediatric migraine.Methods: We prospectively recruited 120 subjects, who never took migraine-...
Main Authors: | Pi-Chuan Fan, Ping-Hung Kuo, Ming Tatt Lee, Shu-Hui Chang, Lih-Chu Chiou |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fneur.2019.00010/full |
Similar Items
-
Age-Dependent Anti-migraine Effects of Valproic Acid and Topiramate in Rats
by: Pokai Huang, et al.
Published: (2018-09-01) -
Prophylactic Treatment for Migraine in Children: Amitriptyline or Topiramate?
by: Gonca Bektaş
Published: (2017-06-01) -
Association of serum levels of calcitonin gene-related peptide and cytokines during migraine attacks
by: Dawei Han
Published: (2019-01-01) -
Erenumab: A novel calcitonin gene-related peptide receptor antagonist developed specifically for migraine prevention
by: Shuchita Garg, et al.
Published: (2020-01-01) -
The Efficacy and Safety of Topiramate in the Prevention of Pediatric Migraine: An Update Meta-Analysis
by: Xinwei Wu, et al.
Published: (2020-02-01)